Insider Trading & Ownership - Tsuchimoto Kim R

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Tsuchimoto Kim R

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-30
Exercise
2024-07-02
6:08 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
9,957$0131,841
(Direct)
View
2024-06-30
Tax Withholding
2024-07-02
6:08 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
2,998$0.731131,841
(Direct)
View
2024-03-31
Tax Withholding
2024-04-02
8:33 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
4,082$0.681134,839
(Direct)
View
2024-03-31
Exercise
2024-04-02
8:33 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
9,956$0134,839
(Direct)
View
2023-12-31
Exercise
2024-01-03
7:34 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
11,188$0234,477
(Direct)
View
2023-12-31
Tax Withholding
2024-01-03
7:34 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
4,578$0.3402234,477
(Direct)
View
2023-09-30
Tax Withholding
2023-10-03
7:36 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
3,444$0.6199143,499
(Direct)
View
2023-09-30
Exercise
2023-10-03
7:36 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
9,956$0143,499
(Direct)
View
2023-06-30
Exercise
2023-07-03
6:46 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
14,846$0146,943
(Direct)
View
2023-06-30
Tax Withholding
2023-07-03
6:46 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
5,104$0.855146,943
(Direct)
View
2023-03-31
Exercise
2023-04-04
5:16 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
5,067$0152,047
(Direct)
View
2023-03-31
Tax Withholding
2023-04-04
5:16 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
1,842$1.39152,047
(Direct)
View
2023-02-01
Option Award
2023-02-03
6:45 pm
N/A
2033-02-01
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
180,922$0238,070
(Direct)
View
2022-12-31
Tax Withholding
2023-01-03
4:03 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
2,569$2.3775,655
(Direct)
View
2022-12-31
Exercise
2023-01-03
4:03 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
6,297$075,655
(Direct)
View
2022-09-30
Exercise
2022-10-03
7:59 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
5,066$078,224
(Direct)
View
2022-09-30
Tax Withholding
2022-10-03
7:59 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
1,753$1.5278,224
(Direct)
View
2022-06-30
Tax Withholding
2022-07-01
4:05 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
3,083$2.29979,977
(Direct)
View
2022-06-30
Exercise
2022-07-01
4:05 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
8,913$079,977
(Direct)
View
2022-03-31
Tax Withholding
2022-04-01
5:28 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
500$2.5583,060
(Direct)
View
2022-03-31
Exercise
2022-04-01
5:28 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
1,221$083,060
(Direct)
View
2022-02-02
Option Award
2022-02-04
7:36 pm
N/A
2032-02-01
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
142,927$0160,040
(Direct)
View
2022-01-01
Exercise
2022-01-04
2:31 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
1,231$07,376
(Direct)
View
2022-01-01
Tax Withholding
2022-01-04
2:31 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
505$3.217,376
(Direct)
View
2021-12-31
Exercise
2022-01-04
2:27 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
1,221$018,841
(Direct)
View
2021-12-31
Tax Withholding
2022-01-04
2:27 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
501$3.2118,841
(Direct)
View
2021-09-30
Tax Withholding
2021-10-01
7:29 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
423$4.8719,342
(Direct)
View
2021-09-30
Exercise
2021-10-01
7:29 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
1,221$019,342
(Direct)
View
2021-06-30
Exercise
2021-07-02
5:13 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
2,442$019,765
(Direct)
View
2021-06-30
Tax Withholding
2021-07-02
5:13 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
823$5.8919,765
(Direct)
View
2021-01-26
Option Award
2021-01-28
6:53 pm
N/A
2031-01-25
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
46,963$050,655
(Direct)
View
2021-01-01
Exercise
2021-01-05
6:23 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
1,231$04,744
(Direct)
View
2021-01-01
Tax Withholding
2021-01-05
6:23 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
504$6.124,744
(Direct)
View
2020-01-31
Option Award
2020-02-20
9:02 pm
N/A
N/A
Monopar TherapeuticsMNPRTsuchimoto Kim R
Chief Financial Officer
25,378$025,378
(Direct)
View